BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Diagnosis
13 results:

  • 1. Disparities in refusal of surgery for gynecologic cancer.
    Samuel D; Kwon D; Huang M; Zhao W; Roy M; Tabuyo-Martin A; Siemon J; Schlumbrecht MP; Pearson JM; Sinno AK
    Gynecol Oncol; 2023 Jul; 174():1-10. PubMed ID: 37141816
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Is complete mesocolic excision or total mesorectal excision necessary during cytoreductive surgery in ovarian peritoneal carcinomatosis with colonic involvement?
    Karadayi K; Karabacak U
    Acta Chir Belg; 2023 Apr; 123(2):124-131. PubMed ID: 34253150
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Increased Malignancy Rate in Children With IgE Deficiency: A Single-center Experience.
    Ferastraoaru D; Schwartz D; Rosenstreich D
    J Pediatr Hematol Oncol; 2021 May; 43(4):e472-e477. PubMed ID: 32769562
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Prognostic value of radiological recurrence patterns in ovarian cancer.
    Roze JF; Veldhuis WB; Hoogendam JP; Verheijen RHM; Scholten RJPM; Zweemer RP
    Gynecol Oncol; 2020 Jun; 157(3):606-612. PubMed ID: 32171567
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The French national network dedicated to rare gynecological cancers diagnosis and management could improve the quality of surgery in daily practice of granulosa cell tumors. A TMRG and GINECO group Study.
    Lenck C; Chopin N; Gouy S; Bonsang-Kitzis H; Martinez-Gomez C; Radosevic-Robin N; Martin S; Lefeuvre-Plesse C; Lambaudie E; Leblanc E; Guyon F; Classe JM; Ramanah R; Beurrier F; Angeles MA; Pomel C; Joly F; de la Motte Rouge T; Provansal M; Lesoin A; Floquet A; Berton D; Kalbacher E; Chakiba C; Meeus P; Selle F; Treilleux I; Lecuru F; Pautier P; Ray-Coquard I
    Gynecol Oncol; 2020 Apr; 157(1):78-84. PubMed ID: 32131977
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.
    Zhang L; Luo M; Yang H; Zhu S; Cheng X; Qing C
    J Ovarian Res; 2019 Feb; 12(1):19. PubMed ID: 30786925
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of ovarian cancer Screening (UKCTOCS).
    Fourkala EO; Burnell M; Cox C; Ryan A; Salter LC; Gentry-Maharaj A; Parmar M; Jacobs I; Menon U
    BMJ Open; 2014 Sep; 4(9):e005400. PubMed ID: 25252818
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. 18F-FDG PET-CT and USG/CT in benign and malignant ovarian tumors with postoperative histopathological correlation.
    Kuyumcuoğlu U; Guzel AI; Celik Y; Erdemoğlu M; Komek H
    Ginekol Pol; 2011 Aug; 82(8):602-6. PubMed ID: 21957605
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Reducing time to diagnosis does not improve outcomes for women with symptomatic ovarian cancer: a report from the Australian ovarian cancer Study Group.
    Nagle CM; Francis JE; Nelson AE; Zorbas H; Luxford K; de Fazio A; Fereday S; Bowtell DD; Green AC; Webb PM
    J Clin Oncol; 2011 Jun; 29(16):2253-8. PubMed ID: 21537035
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Allelic imbalance in BRCA1 and BRCA2 gene expression and familial ovarian cancer.
    Shen J; Medico L; Zhao H
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):50-6. PubMed ID: 21119070
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Markov-modeling for the administration of platinum analogues and paclitaxel as first-line chemotherapy as well as topotecan and liposomal doxorubicin as second-line chemotherapy with epithelial ovarian carcinoma.
    Fedders M; Hartmann M; Schneider A; Kath R; Camara O; Oelschläger H
    J Cancer Res Clin Oncol; 2007 Sep; 133(9):619-25. PubMed ID: 17458562
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
    Foulkes WD; Thiffault I; Gruber SB; Horwitz M; Hamel N; Lee C; Shia J; Markowitz A; Figer A; Friedman E; Farber D; Greenwood CM; Bonner JD; Nafa K; Walsh T; Marcus V; Tomsho L; Gebert J; Macrae FA; Gaff CL; Paillerets BB; Gregersen PK; Weitzel JN; Gordon PH; MacNamara E; King MC; Hampel H; De La Chapelle A; Boyd J; Offit K; Rennert G; Chong G; Ellis NA
    Am J Hum Genet; 2002 Dec; 71(6):1395-412. PubMed ID: 12454801
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. BRCA2 gene mutations in Greek patients with familial breast cancer.
    Armakolas A; Ladopoulou A; Konstantopoulou I; Pararas B; Gomatos IP; Kataki A; Konstadoulakis MM; Stathopoulos GP; Markopoulos C; Leandros E; Gogas I; Yannoukakos D; Androulakis G
    Hum Mutat; 2002 Jan; 19(1):81-2. PubMed ID: 11754111
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.